Projecting corporate health plan utilization and charges from annual ICD-9-CM diagnostic rates: A value-added opportunity for pathologists

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 11, 1997, Pages 1187-1191

  Elevitch, Franklin R ^a   Silvers, Abraham ^a   Sahl, Jack D ^a  

^a Health Care Engineering   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC TEST; EMPLOYEE; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; RESOURCE ALLOCATION;

ADULT; AGED; CALIFORNIA; COHORT STUDIES; DISEASE; FEES AND CHARGES; FORECASTING; HEALTH PLAN IMPLEMENTATION; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MIDDLE AGED; PATHOLOGY, CLINICAL;

EID: 0031412220     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Bodenheimer T, Grumback K. The reconfiguration of US medicine, JAMA, 1995;271:85-90.
2. Grimaldi PL, Micheletti JA. Diagnosis Related Groups: A Practitioner's Guide. Chicago, III: Pluribus Press Inc; 1983.
3. Physicians' Current Procedural Terminology CPT 95, Chicago, III: American Medical Association; 1994.
4. The International Classfication of Diseases, 9th revision. Clinical Modification ICD-9-CM, Ann Arbor, Mich: Commission on Professional and Hospital Activities; 1986.
5. Model Compliance Plan for Clinical laboratories, MHS Office of Inspector General, January 24, 1997. http://www.sluonline.sba.gov/ignet/internal/hhs/ cpcl.html